Mark C. Wiggins - 28 Jan 2022 Form 4 Insider Report for Tracon Pharmaceuticals, Inc. (TCON)

Role
Chief Business Officer
Signature
/s/ Scott B. Brown, Attorney-in-Fact
Issuer symbol
TCON
Transactions as of
28 Jan 2022
Transactions value $
$0
Form type
4
Date filed
01 Feb 2022, 16:00
Previous filing
28 May 2021
Next filing
09 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCON Employee Stock Option (Right to Buy) Award $0 +80K $0.00 80K 28 Jan 2022 Common Stock 80K $2.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to this option shall vest on the first anniversary of the Grant Date shown in column 3 above. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter, on the last day of each month.